期刊文献+

凋亡抑制蛋白Survivin的表达与肝细胞肝癌预后的关系 被引量:2

The evaluation of Survivin protein expression for the prognosis of postoperative patients with hepatocellular carcinoma
原文传递
导出
摘要 目的 评价Survivin、VEGF和MMP 2在肝细胞肝癌中的表达与HCC预后的关系。方法 采用免疫组化链霉素抗生物素 过氧化物酶 (S P)法检测 6 7例肝癌组织、相应癌旁组织及正常肝脏标本中Survivin、VEGF和MMP 2的表达。选择可能对HCC手术切除患者预后产生影响的临床及生物学因素进行量化 ,依次引入COX风险模型。应用Kaplan Meier法计算累计生存率 ,并经Log rank检验。结果 多因素分析 (COX模型 )显示Survivin的表达、VEGF的表达、肝功能Child分级是与预后相关的独立影响因素。各因素均与术后死亡率有正相关。结论 患者的肝功能分级情况、Survivin、VEGF的表达水平是HCC患者手术后生存的独立危险因素。 Objective To evaluate the correlation between the expression of Survivin、VEGF and MMP 2 and the prognosis of patients with hepatocellular carcinoma Methods Expressions of Survivin、 VEGF and MMP 2 were detected by immunohistochemical S P method in 67 postoperative HCC cases Twelve candidate factors associated with long term survival were analyzed by Kaplan Meier Log rank estimation A multivariative Survival analysis of these individual variables was undertaken using the cumulative survival rate by the COX proportional hazards model Results A multivariative analysis determined three independent significant factors influencing overall cumulative survival including Survivin, VEGF, liver function (Child grade) The three prognostic factors predicted an increased risk of death from HCC Conclusion Survivin, VEGF, liver function, particularly the Child Pugh classification are the most significant prognostic factors for HCC patients undergoing hepatic resection
出处 《中华普通外科杂志》 CSCD 北大核心 2004年第12期755-757,共3页 Chinese Journal of General Surgery
基金 山东省青年医学科研基金资助 (2 0 0 3 3 4)
关键词 表达 预后 VEGF HCC 肝细胞肝癌 患者 凋亡抑制蛋白 MMP-2 肝功能分级 术后死亡 Carcinoma, hepatocellular Prognosis Survivin gene COX proportional hazards model
  • 相关文献

参考文献4

  • 1Ikeguchi M, Hirooka Y, Ksibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer, 2002,95:1938-1945.
  • 2Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlates with apoptosis, proliferation and angiogenesis during human colorectal tumorigenesis. Cancer, 2001,91:2026-2032.
  • 3Yeh CN, Chen MF, Lee WC, et al. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol, 2002,81:195-202.
  • 4Lise M, Bacchetti S, Da Pian P, et al. Prognosis factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer, 1998,82:1028-1036.

同被引文献24

  • 1Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry, 2001,40 : 1117-1123.
  • 2Ito T, Shiraki K, Sugimoto K, et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology, 2000,31:1080-1085.
  • 3Sohda T, Yun K, Iwatw K, et al. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab Invest, 1996, 75:307-311.
  • 4Su Q, Liu YF, Zhang JF, et al. Expression of insulin-like growth factor Ⅱ in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology, 1994,20:788-799.
  • 5Alexia C, Lasfer M, Groyer A. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatorna cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines. Ann N Y Acad Sci, 2004, 1030:219-229.
  • 6Lund P, Schubert D, Niketeghad F, et al. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulinlike growth factor-Ⅱ. Cancer Lett,2004,206:85-96.
  • 7Mukherjee B, Ghosh S, Das T, et al. Characterization of insulinlike-growth factor Ⅱ (IGF Ⅱ) mRNA positive hepatic altered foci and IGF Ⅱ expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats. J Carcinog, 2005,10 : 12.
  • 8Zhang N, Siegel K, Odenthal M, et al. The role of insulin-like growth factor Ⅱ in the malignant transformation of rat liver oval cells. Hepatology, 1997,25:900-905.
  • 9于利利,王泽华.凋亡抑制蛋白Livin shRNA真核表达载体的构建[J].华中科技大学学报(医学版),2007,36(4):489-491. 被引量:6
  • 10Sib|ey CR, Seow Y, Wood MJ. Novel RNA-based strategies for therapeutic gene silencing[J]. Molecular Therapy, 2010,18(3):466- 476.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部